Caroline Baumal - 04 Jan 2024 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Signature
/s/ David Watson, attorney-in-fact for Caroline Baumal
Issuer symbol
APLS
Transactions as of
04 Jan 2024
Net transactions value
-$165,207
Form type
4
Filing time
05 Jan 2024, 16:14:02 UTC
Previous filing
05 Jan 2023
Next filing
17 Jan 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale $165,207 -2,751 -7.7% $60.05 32,931 04 Jan 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares sold to cover tax withholding on a Restricted Stock Unit release.